# Durability Extension Study to Assess Clinical Activity and Safety of Enobosarm (GTx-024) in Stress Urinary Incontinence

> **NCT03508648** · PHASE2 · WITHDRAWN · sponsor: **GTx**

## Conditions studied

- Stress Urinary Incontinence

## Interventions

- **DRUG:** GTx-024
- **DRUG:** Matching Placebo

## Key facts

- **NCT ID:** NCT03508648
- **Lead sponsor:** GTx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-05-28
- **Primary completion:** 2018-09-21
- **Final completion:** 2018-09-21
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of efficacy from primary study
- **Last updated:** 2023-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03508648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03508648, "Durability Extension Study to Assess Clinical Activity and Safety of Enobosarm (GTx-024) in Stress Urinary Incontinence". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03508648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*